iCamumo Biotherapeutics
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $75M
Investors
- 7
About iCamumo Biotherapeutics
, trading as iCamumo Biotherapeutics, is a biotechnology company mainly involved in the field of iPSC (induced pluripotent stem cells) reprogramming, gene editing, stem cell differentiation. The company built a 2,500 square meter GMP pilot plant in Suzhou and has developed multiple iPSC-CAB-NK cell therapeutic products for solid tumors in June 2021. iCamumo Biotherapeutics provides therapy drugs research and trial development, cellular technology development and application for customer, focusing on immunotherapy and regenerative medicine therapies based on its independently developed next-generation iPSC cell reprogramming platform, AI (artificial intelligence)-driven iPSC cell and organoid differentiation platform, precision gene editing platform, and advanced cell manufacturing. The company generates revenue from developing cell therapy drugs derived from iPSCs.
Who invested in iCamumo Biotherapeutics
7 investors across 4 rounds
See all investors in iCamumo Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iCamumo Biotherapeutics
Who invested in iCamumo Biotherapeutics?
iCamumo Biotherapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iCamumo Biotherapeutics raised?
iCamumo Biotherapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did iCamumo Biotherapeutics last raise money?
iCamumo Biotherapeutics's most recent round on record is a Series A, in Mar 2026.
What does iCamumo Biotherapeutics do?
, trading as iCamumo Biotherapeutics, is a biotechnology company mainly involved in the field of iPSC (induced pluripotent stem cells) reprogramming, gene editing, stem cell differentiation.
Where is iCamumo Biotherapeutics headquartered?
iCamumo Biotherapeutics is headquartered in Suzhou, China.
Which VCs invest in companies like iCamumo Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at iCamumo Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iCamumo Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.